Parainfluenza Virus type 3 Antibody (1256): sc-58177

Parainfluenza Virus type 3 Antibody (1256) is a mouse monoclonal IgG2a antibody that detects Parainfluenza Virus type 3 protein by immunofluorescence (IF). Anti-Parainfluenza Virus type 3 antibody (1256) is available as a non-conjugated format for studying this viral protein. Parainfluenza Virus type 3 protein plays a crucial role in causing respiratory infections, particularly in young children and immunocompromised individuals. Parainfluenza Virus type 3 (1256) monoclonal antibody enables research into viral replication and pathogenesis mechanisms, including host cell entry and immune response modulation. Understanding Parainfluenza Virus type 3 protein function is vital for developing targeted therapies and vaccines by revealing how viral immune evasion and disease progression occur. Anti-Parainfluenza Virus type 3 antibody (1256) offers high specificity and sensitivity for investigating viral biology and human health impacts.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

Parainfluenza Virus type 3 Antibody (1256) References:

1. [Parainfluenza virus type 4 infections].  |  García García, ML., et al. 2002. An Esp Pediatr. 57: 116-20. PMID: 12139865
2. The genome length of human parainfluenza virus type 2 follows the rule of six, and recombinant viruses recovered from non-polyhexameric-length antigenomic cDNAs contain a biased distribution of correcting mutations.  |  Skiadopoulos, MH., et al. 2003. J Virol. 77: 270-9. PMID: 12477832
3. Human parainfluenza virus type 4 is incapable of evading the interferon-induced antiviral effect.  |  Nishio, M., et al. 2005. J Virol. 79: 14756-68. PMID: 16282476
4. Incomplete replication of human parainfluenza virus type 2 in mouse L929 cells.  |  Ito, Y., et al. 1989. Arch Virol. 108: 137-44. PMID: 2480761
5. Dynamics of nosocomial parainfluenza virus type 3 and influenza virus infections at a large German University Hospital between 2012 and 2019.  |  Martin, D., et al. 2021. Diagn Microbiol Infect Dis. 99: 115244. PMID: 33253961
6. Caprine parainfluenza virus type 3 N protein promotes viral replication via inducing apoptosis.  |  Li, J., et al. 2021. Vet Microbiol. 259: 109129. PMID: 34087675
7. Reemergence of Parainfluenza Virus Type 3 and Respiratory Syncytial Virus Infections During the COVID-19 Pandemic.  |  Park, K., et al. 2023. Ann Lab Med. 43: 114-116. PMID: 36045068
8. Generation of a photocontrollable recombinant bovine parainfluenza virus type 3.  |  Okura, T., et al. 2023. Microbiol Immunol. 67: 204-209. PMID: 36609846
9. Immunochemical study of parainfluenza virus (type 2) in amnion cells.  |  De Vaux St Cyr, C. and Howe, C. 1966. J Bacteriol. 91: 1911-6. PMID: 4287073
10. Growth studies of parainfluenza virus (type 2).  |  Howe, C., et al. 1970. Arch Gesamte Virusforsch. 29: 50-62. PMID: 4318110
11. Parainfluenza virus type 2 meningitis and parotitis in an 11-year-old child.  |  Jantausch, BA., et al. 1995. South Med J. 88: 230-1. PMID: 7839170
12. Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.  |  Nishio, M., et al. 1996. J Gen Virol. 77 (Pt 10): 2457-63. PMID: 8887478